Angiotensin II and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Angiotensin II and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: angiotensin II
Brand name: Giapreza
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Angiotensin II-Insulin degludec
- Angiotensin II-Insulin Degludec (U-100) Prefilled Pens
- Angiotensin II-Insulin Degludec (U-100) Vials
- Angiotensin II-Insulin Degludec (U-200) Prefilled Pens
- Angiotensin II-Insulin degludec and liraglutide
- Angiotensin II-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Angiotensin II Acetate
- Insulin aspart, recombinant Subcutaneous-Angiotensin ii Intravenous
- Insulin aspart, recombinant Subcutaneous-Anidulafungin
- Insulin aspart, recombinant Subcutaneous-Anidulafungin Intravenous
- Insulin aspart, recombinant Subcutaneous-Animi-3
- Insulin aspart, recombinant Subcutaneous-Animi-3 with Vitamin D